BRIEF published on 04/11/2025 at 20:05, 1 year 1 month ago Oxurion Publishes its 2024 Annual Report and Convenes its General Meeting Forward-looking Statements Annual Report 2024 Ophthalmic Therapies Shareholders' Meetings Oxurion NV
PRESS RELEASE published on 04/11/2025 at 20:05, 1 year 1 month ago Publication Annual Report - Annual Shareholders' Meeting Oxurion NV releases its annual report for the financial year 2024 and convenes its Annual Shareholders' Meeting in Leuven, Belgium. Developing ophthalmic therapies for retinal disease Shareholders' Meeting Annual Report Ophthalmic Therapies Oxurion NV Retinal Disease
BRIEF published on 04/04/2025 at 14:05, 1 year 1 month ago Oxurion General Meeting Postponed General Meeting Biopharmaceuticals Report Ophthalmic Therapies Oxurion
PRESS RELEASE published on 04/04/2025 at 14:00, 1 year 1 month ago Postponement Annual Shareholders Meeting Oxurion NV postponed its Annual Shareholders Meeting to May 13, 2025, due to pending annual accounts. The biopharmaceutical company, focused on ophthalmic therapies, is based in Leuven, Belgium Biopharmaceutical Annual Shareholders Meeting Postponed Ophthalmic Therapies Oxurion NV
BRIEF published on 04/02/2025 at 18:05, 1 year 1 month ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Actions Transparency Atlas Special Opportunities Oxurion Biopharmacy
PRESS RELEASE published on 04/02/2025 at 18:00, 1 year 1 month ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV, a biopharmaceutical company, received a transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing under Belgian legislation Transparency Notification Shareholding Threshold Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC
BRIEF published on 03/27/2025 at 18:05, 1 year 2 months ago Oxurion receives adjusted transparency notification Transparency Notification Shareholding Oxurion Atlas Special Opportunities II Brussels Stock Exchange
PRESS RELEASE published on 03/27/2025 at 18:00, 1 year 2 months ago Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received an amended transparency notification from Atlas Special Opportunities II, LLC regarding the sale of voting securities. This press release replaces the one from March 18, 2025 Transparency Notification Euronext Brussels Oxurion NV Retinal Disease Therapies Atlas Special Opportunities II
BRIEF published on 03/24/2025 at 18:05, 1 year 2 months ago Oxurion Announces Capital Increase Following Convertible Bond Conversion Convertible Bonds Capital Increase Atlas Special Opportunities Ophthalmic Therapies Oxurion
PRESS RELEASE published on 03/24/2025 at 18:00, 1 year 2 months ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC converts bonds in Oxurion, resulting in EUR 150,000 capital increase. Oxurion focuses on developing therapeutics for vision care Capital Increase Therapeutics Vision Care Atlas Special Opportunities LLC Oxurion
Published on 05/30/2026 at 04:00, 3 hours 40 minutes ago Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
Published on 05/30/2026 at 02:40, 5 hours ago BEACN Announces Financial Results for the First Quarter of 2026 and Update on Loan
Published on 05/30/2026 at 01:30, 6 hours 10 minutes ago Core Critical Approved for Listing on OTCQB(R) Venture Market
Published on 05/30/2026 at 00:31, 7 hours 9 minutes ago Gold Basin Resources Provides Updates on Arrangement with CANEX
Published on 05/29/2026 at 23:00, 8 hours 40 minutes ago The Fresh Factory Reports Q1 2026 Financial Results with 17% Billed Revenue Growth, Completes New Facility Retrofit
Published on 05/29/2026 at 21:42, 9 hours 57 minutes ago EQS-Adhoc: Consortium reaches definitive agreement to acquire 4finance Holding’s core consumer lending assets and launch Mellenu Holding
Published on 05/29/2026 at 21:30, 10 hours 10 minutes ago Mutares portfolio company F.lli Ferrari Holding has signed an agreement for the partial sale of its Benelux operations to HMF Group
Published on 05/29/2026 at 20:00, 11 hours 40 minutes ago Brödernas publishes quarterly report for Jan-Mar 2026
Published on 05/29/2026 at 19:46, 11 hours 53 minutes ago CPI PROPERTY GROUP publishes financial results for the first quarter of 2026
Published on 05/29/2026 at 19:27, 12 hours 12 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/29/2026 at 22:00, 9 hours 40 minutes ago Information on the Annual Financial Statements 2025
Published on 05/29/2026 at 18:00, 13 hours 40 minutes ago Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market
Published on 05/29/2026 at 12:00, 19 hours 40 minutes ago Capital increase through exercise of subscription rights
Published on 05/29/2026 at 10:30, 21 hours 10 minutes ago bioMérieux invests in France with a new facility to produce innovative diagnostics for the European market
